Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthc...
Neuraxpharm Group and Minoryx Therapeutics have announced that the European Commission has granted marketing authorisati...
Deep Origin and partners in the Pharmacological Research and Evaluation through Digital Integration and Clinical Trials ...
Germfree, a full-lifecycle engineering and manufacturing partner for mission-critical environments across life sciences,...
InnoCare Pharma, a China-based biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, ha...
United Immunity, a clinical stage biotechnology company, has raised a total of ¥2.2 billion in private financing, co...
Aptar Pharma, a global leader in drug delivery, dosing and protection technologies and services, has announced a new res...
Neurology, once considered the graveyard of pharma development, is entering a new era. After years of high clinical fail...
On March 13, 2026, China’s National Medical Products Administration (NMPA) granted Class III registration to NEO, ...
Amyloid-targeting therapies have arrived across Asia-Pacific faster than the infrastructure needed to decide who should ...
The success of mRNA vaccines during the COVID-19 pandemic transformed the technology from a promising scientific approac...
How do you view the multiple myeloma market in APAC, addressing its affordability and accessibility? Asia Pacific is at...
Novotech, the global full-service clinical research organisation (CRO) and scientific advisory company, has reached agre...
China-based Sanyou Biopharmaceuticals and NovoCodex Biopharmaceuticals have jointly announced that the two companies hav...
Novo Nordisk has announced that Singapore's Health Sciences Authority (HSA) has approved Wegovy® (once-weekly i...
The latest personalised mRNA cancer vaccine data have renewed attention on individualized oncology. How significant is t...
Boomray Pharmaceuticals, a China-based clinical-stage biotechnology company pioneering innovative radioligand therapies ...
Australia-based Telix Pharmaceuticals has signed a strategic agreement to lead a merger with ITM Isotope Technologies Mu...
South Korea-based 1ST Biotherapeutics, Inc. and SK Biopharmaceuticals have entered into an exclusive global li...
Swiss pharma firm Roche has announced the grand opening of the Roche Genentech Innovation Center Boston, expanding Roche...
India-based Gujarat Themis Biosyn Limited (GTBL) has announced the completion of the acquisition of 100% equity sharehol...
Japan-based Takeda Pharmaceutical Company, through its Indian subsidiary Takeda Biopharmaceuticals India, and Dr. Reddy&...
Eisai Co. and Biogen Inc. have announced that LEQEMBI® Pen, the subcutaneous (SC) formulation of the anti-amyloid be...
Ask anyone who negotiates drug licences for a living what changed in the last two years, and you will usually get the sa...
Shilpa Biologicals, an India-based integrated biologics development and manufacturing organisation, has announced an exc...
